Raia Drogasil S.A. (RADLY)
USD 3.57
(-0.14%)
USD 3.57
(-0.14%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10.2 Billion BRL | 15.87% |
| 2022 | 8.8 Billion BRL | 22.25% |
| 2021 | 7.2 Billion BRL | 22.32% |
| 2020 | 5.89 Billion BRL | 13.33% |
| 2019 | 5.19 Billion BRL | 16.93% |
| 2018 | 4.44 Billion BRL | 11.47% |
| 2017 | 3.98 Billion BRL | 13.81% |
| 2016 | 3.5 Billion BRL | 29.09% |
| 2015 | 2.71 Billion BRL | 28.64% |
| 2014 | 2.11 Billion BRL | 22.67% |
| 2013 | 1.72 Billion BRL | 15.24% |
| 2012 | 1.49 Billion BRL | 107.91% |
| 2011 | 717.92 Million BRL | 50.07% |
| 2010 | 478.39 Million BRL | 19.94% |
| 2009 | 398.85 Million BRL | 35.59% |
| 2008 | 294.15 Million BRL | 29.68% |
| 2007 | 226.83 Million BRL | 22.93% |
| 2006 | 184.51 Million BRL | 23.7% |
| 2005 | 149.16 Million BRL | 23.3% |
| 2004 | 120.97 Million BRL | 12.42% |
| 2003 | 107.6 Million BRL | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.22 Billion BRL | -17.23% |
| 2024 Q2 | 2.48 Billion BRL | 11.75% |
| 2023 Q4 | 2.68 Billion BRL | 3.68% |
| 2023 Q3 | 2.59 Billion BRL | -0.76% |
| 2023 Q1 | 2.32 Billion BRL | -0.7% |
| 2023 Q2 | 2.61 Billion BRL | 12.42% |
| 2023 FY | 10.2 Billion BRL | 15.87% |
| 2022 Q4 | 2.33 Billion BRL | 5.1% |
| 2022 Q1 | 1.92 Billion BRL | -1.2% |
| 2022 Q2 | 2.31 Billion BRL | 20.21% |
| 2022 FY | 8.8 Billion BRL | 22.25% |
| 2022 Q3 | 2.22 Billion BRL | -4.03% |
| 2021 Q3 | 1.81 Billion BRL | 1.02% |
| 2021 FY | 7.2 Billion BRL | 22.32% |
| 2021 Q4 | 1.95 Billion BRL | 7.51% |
| 2021 Q1 | 1.64 Billion BRL | 0.47% |
| 2021 Q2 | 1.79 Billion BRL | 9.45% |
| 2020 Q1 | 1.44 Billion BRL | 2.19% |
| 2020 Q2 | 1.32 Billion BRL | -8.44% |
| 2020 Q4 | 1.63 Billion BRL | 9.31% |
| 2020 FY | 5.89 Billion BRL | 13.33% |
| 2020 Q3 | 1.49 Billion BRL | 13.25% |
| 2019 Q3 | 1.33 Billion BRL | 3.66% |
| 2019 FY | 5.19 Billion BRL | 16.93% |
| 2019 Q1 | 1.16 Billion BRL | -3.02% |
| 2019 Q2 | 1.28 Billion BRL | 10.99% |
| 2019 Q4 | 1.41 Billion BRL | 5.58% |
| 2018 Q1 | 4.46 Billion BRL | 326.31% |
| 2018 FY | 4.44 Billion BRL | 11.47% |
| 2018 Q4 | 1.19 Billion BRL | -75.42% |
| 2018 Q3 | 4.87 Billion BRL | 341.37% |
| 2018 Q2 | 1.1 Billion BRL | -75.24% |
| 2017 Q1 | 921.62 Million BRL | -0.08% |
| 2017 Q4 | 1.04 Billion BRL | 2.53% |
| 2017 FY | 3.98 Billion BRL | 13.81% |
| 2017 Q3 | 1.02 Billion BRL | 2.07% |
| 2017 Q2 | 999.72 Million BRL | 8.47% |
| 2016 Q4 | 922.34 Million BRL | 2.48% |
| 2016 FY | 3.5 Billion BRL | 29.09% |
| 2016 Q1 | 756.94 Million BRL | 2.49% |
| 2016 Q3 | 900.03 Million BRL | -2.68% |
| 2016 Q2 | 924.82 Million BRL | 22.18% |
| 2015 FY | 2.71 Billion BRL | 28.64% |
| 2015 Q2 | 695.9 Million BRL | 17.86% |
| 2015 Q4 | 738.55 Million BRL | 7.09% |
| 2015 Q3 | 689.63 Million BRL | -0.9% |
| 2015 Q1 | 590.46 Million BRL | 2.22% |
| 2014 FY | 2.11 Billion BRL | 22.67% |
| 2014 Q1 | 462.1 Million BRL | -0.5% |
| 2014 Q2 | 522.25 Million BRL | 13.02% |
| 2014 Q3 | 548.2 Million BRL | 4.97% |
| 2014 Q4 | 577.62 Million BRL | 5.37% |
| 2013 Q4 | 464.41 Million BRL | 2.79% |
| 2013 FY | 1.72 Billion BRL | 15.24% |
| 2013 Q3 | 451.78 Million BRL | 6.8% |
| 2013 Q2 | 423.03 Million BRL | 11.05% |
| 2013 Q1 | 380.94 Million BRL | -4.69% |
| 2012 Q1 | 325.56 Million BRL | 3.66% |
| 2012 FY | 1.49 Billion BRL | 107.91% |
| 2012 Q4 | 399.67 Million BRL | 5.04% |
| 2012 Q3 | 380.48 Million BRL | -1.66% |
| 2012 Q2 | 386.92 Million BRL | 18.85% |
| 2011 FY | 717.92 Million BRL | 50.07% |
| 2011 Q3 | 144.1 Million BRL | 1.35% |
| 2011 Q2 | 142.17 Million BRL | 20.93% |
| 2011 Q1 | 117.56 Million BRL | -6.62% |
| 2011 Q4 | 314.08 Million BRL | 117.96% |
| 2010 Q1 | 105.37 Million BRL | -0.6% |
| 2010 FY | 478.39 Million BRL | 19.94% |
| 2010 Q4 | 125.89 Million BRL | 2.87% |
| 2010 Q3 | 122.38 Million BRL | -1.9% |
| 2010 Q2 | 124.74 Million BRL | 18.39% |
| 2009 FY | 398.85 Million BRL | 35.59% |
| 2009 Q4 | 106 Million BRL | 1.45% |
| 2009 Q3 | 104.49 Million BRL | -0.2% |
| 2009 Q2 | 104.69 Million BRL | 25.15% |
| 2009 Q1 | 83.65 Million BRL | 0.0% |
| 2008 FY | 294.15 Million BRL | 29.68% |
| 2007 FY | 226.83 Million BRL | 22.93% |
| 2006 FY | 184.51 Million BRL | 23.7% |
| 2005 FY | 149.16 Million BRL | 23.3% |
| 2004 FY | 120.97 Million BRL | 12.42% |
| 2003 FY | 107.6 Million BRL | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -7512.975% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | -853458428.428% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | -83746.177% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -11495.851% |
| MedGen, Inc. | 1.05 USD | -972129904661.905% |
| Omni Health, Inc. | 1.55 Million USD | -657360.953% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | -32447493.617% |
| Pineapple, Inc. | -1.02 Million USD | 996239.718% |
| ScripsAmerica, Inc. | 27.59 Million USD | -36887.104% |